Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

TNBC

  • You have access
    Snail Mucus Enhances Chemosensitivity of Triple-negative Breast Cancer Via Activation of the Fas Pathway
    CHIEN-YI HO, DAI-WEI HU, BO-RONG CHEN, CHUN-CHUN YANG, CHUN-HSU YAO, TIEN NI, WEI-CHUAN HO, YUEH-SHENG CHEN, CHIH-YEN TU, WEI-CHAO CHANG, YANG-CHANG WU, CHIH-HSIN TANG, HUI-CHI HUANG, WEI-CHIEN HUANG and TZONG-SHIUN LI
    Anticancer Research February 2022, 42 (2) 845-855; DOI: https://doi.org/10.21873/anticanres.15542
  • You have access
    Combinatorial Cytotoxic Effects of 2,3-Dichloro-5,8-dimethoxy-1,4-naphthoquinone and 4-hydroxytamoxifen in Triple-negative Breast Cancer Cell Lines
    ANASTASIA G.J. ROBINSON, YASMINE M. KANAAN and ROBERT L. COPELAND
    Anticancer Research December 2020, 40 (12) 6623-6635; DOI: https://doi.org/10.21873/anticanres.14687
  • You have access
    MDA-MB-157 Cell Line Presents High Levels of MAD2L2 and Dysregulated Mitosis
    NOMI PERNICONE, LIMOR PERETZ, SHIRA GRINSHPON and TAMAR LISTOVSKY
    Anticancer Research October 2020, 40 (10) 5471-5480; DOI: https://doi.org/10.21873/anticanres.14558
  • You have access
    Novel Imidazo[2,1-b]oxazole Derivatives Inhibit Epithelial Cell Transformation and Triple Negative Breast Cancer Tumorigenesis
    POSHAN YUGAL BHATTARAI, CHANG-HYUN OH, GARAM KIM, MIN SOO KIM, BONG SANG LEE and HONG SEOK CHOI
    Anticancer Research September 2020, 40 (9) 5081-5090; DOI: https://doi.org/10.21873/anticanres.14511
  • You have access
    Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model
    JUN YAMAMOTO, TAKUYA MURATA, NORIHIKO SUGISAWA, TAKASHI HIGUCHI, YOSHIHIKO TASHIRO, HIROTO NISHINO, SACHIKO INUBUSHI, YU SUN, HYEIN LIM, KENTARO MIYAKE, KOICHIRO SHIMOYA, TSUNEHISA NOMURA, JUNICHI KUREBAYASHI, HIROKAZU TANINO, CHIHIRO HOZUMI, MICHAEL BOUVET, SHREE RAM SINGH, ITARU ENDO and ROBERT M. HOFFMAN
    Anticancer Research May 2020, 40 (5) 2475-2479; DOI: https://doi.org/10.21873/anticanres.14217
  • You have access
    A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model
    HYE IN LIM, JUN YAMAMOTO, SACHIKO INUBUSHI, HIROTO NISHINO, YOSHIHIKO TASHIRO, NORIHIKO SUGISAWA, QUINHONG HAN, YU SUN, HEE JUN CHOI, SEOK JIN NAM, MOON BO KIM, JI SUN LEE, CHIHIRO HOZUMI, MICHAEL BOUVET, SHREE RAM SINGH and ROBERT M. HOFFMAN
    Anticancer Research May 2020, 40 (5) 2481-2485; DOI: https://doi.org/10.21873/anticanres.14218
  • You have access
    A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib
    JUN YAMAMOTO, TAKUYA MURATA, YOSHIHIKO TASHIRO, TAKASHI HIGUCHI, NORIHIKO SUGISAWA, HIROTO NISHINO, SACHIKO INUBUSHI, YU SUN, HYEIN LIM, KENTARO MIYAKE, ATSUSHI HONGO, TSUNEHISA NOMURA, WATARU SAITOH, TAKUYA MORIYA, HIROKAZU TANINO, CHIHIRO HOZUMI, MICHAEL BOUVET, SHREE RAM SINGH, ITARU ENDO and ROBERT M. HOFFMAN
    Anticancer Research May 2020, 40 (5) 2509-2514; DOI: https://doi.org/10.21873/anticanres.14221
  • You have access
    The Anticancer and Antioxidant Effects of Muscadine Grape Extracts on Racially Different Triple-negative Breast Cancer Cells
    PATRICIA MENDONCA, AHMED G. DARWISH, VIOLETA TSOLOVA, ISLAM EL-SHARKAWY and KARAM F.A. SOLIMAN
    Anticancer Research August 2019, 39 (8) 4043-4053; DOI: https://doi.org/10.21873/anticanres.13560
  • You have access
    Intrinsic Prognostic Impact of Tumor-infiltrating Lymphocytes in Systemically Untreated Patients With Early-stage Triple-negative Breast Cancer
    JI HYUN PARK, HEE JIN LEE, SAE BYUL LEE, JIN-HEE AHN, JEONG EUN KIM, KYUNG HAE JUNG, GYUNGYUB GONG, BYUNG-HO SON, SEI-HYUN AHN and SUNG-BAE KIM
    Anticancer Research June 2019, 39 (6) 3111-3119; DOI: https://doi.org/10.21873/anticanres.13447
  • You have access
    The Triple-negative Breast Cancer Cell Line MDA-MB 231 Is Specifically Inhibited by the Ionophore Salinomycin
    THOMAS HERO, HELMUT BÜHLER, PASCALINE NGUEMGO KOUAM, BETTINA PRIESCH-GRZESZOWIAK, TATIANA LATEIT and IRENÄUS ANTON ADAMIETZ
    Anticancer Research June 2019, 39 (6) 2821-2827; DOI: https://doi.org/10.21873/anticanres.13410

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire